This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

3 China Stocks That Beat Estimates

Stocks in this article: CWS PUDA CBPO

NEW YORK ( TheStreet) -- China Wind Systems (CWS), Puda Coal (PUDA) and China Biologic Products (CBPO) -- three companies that reported results before market open Monday -- topped analysts' estimates.

China Wind Systems manufactures and sells high-precision forged rolled rings for the wind power and other industries. The company also manufactures and sells textile dyeing and finishing machines in China. The company reported second-quarter earnings of 12 cents per share, beating analysts' estimates of 10 cents per share. Revenues surged 40% year-over-year to $19 million.

Looking forward to fiscal year 2010, the company reaffirmed its revenue guidance in the range of $76.5 to $85 million, while earnings are expected to range between $15.5 million and $16.3 million.

Moreover, the company is in advanced stages of discussions with several wind power component clients to supply shafts and forged products in the second half of 2010. The company believes that the Chinese government's commitment to invest $737.5 billion in new energy would benefit the wind energy sector in China.

Puda Coal is a supplier of high-grade metallurgical coking coal to the industrial sector in China. The company reported second-quarter earnings of 36 cents per share, topping analysts' estimates of 24 cents per share. Revenues soared 72% year-over-year to $82.3 million driven by higher sales volume coupled with higher average selling price.

During the quarter, gross margins almost doubled to 14.7% from 7.5% a year earlier. Also, the company acquired 100% assets and mining rights of the Da Wa Coal and Guanyao Coal mines in Pinglu County for $42.0 million.

China Biologic Products is a biopharmaceutical company engaged in the research, development and manufacturing of plasma-based pharmaceutical products in China. The company reported second-quarter earnings of 49 cents per share, topping analysts' estimates of 36 cents per share. Revenues increased 23% year-over-year to $40.9 million.

Furthermore, the company reaffirmed its 2010 revenue guidance range of $142 million to $149 million, and adjusted net income range of $34 million to $36 million.

Apart from these three companies, eLong (LONG), Perfect World (PWRD), and RINO International (RINO) are expected to report results after market close Monday.

eLong is expected to report earnings of 4 cents per share, Perfect World is expected to report earnings of 69 cents per share, and RINO International's earnings are estimated to be 42 cents per share.

On Aug. 13, BNP Paribas reiterated a buy rating on Perfect World with price target of $40, while Rodman & Renshaw reiterated a market outperform rating on RINO with price target of $40.

Karvy Global Services (www.karvyglobal.com), a subsidiary of the Karvy group (www.karvy.com), provides specialized research in asset classes including stocks, mutual funds and insurance to leading Wall Street firms.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,356.87 +288.00 1.69%
S&P 500 2,012.89 +40.15 2.04%
NASDAQ 4,644.3120 +96.4780 2.12%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs